• Profile
Close

Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma

BMC Cancer Jun 16, 2018

Wang W, et al. - The validity of flow cytometry as a supplemental method to diagnose immunoglobulin D (IgD) multiple myeloma (MM) (by detecting the heavy chain of cytoplasmic IgD) was tested. From patients with MM, including five with IgD MM, bone marrow (BM) samples were collected. Each patient’s BM sample was analyzed for antibodies to four types of heavy chains of immunoglobulin (e.g., IgA, IgG, IgM, and IgD) using flow cytometry. Based on the findings, it was concluded that, by enabling cytoplasmic IgD detection, flow cytometry affords a convenient, sensitive and supplemental method to diagnose IgD MM.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay